ArticleACS sensors2025
Explainable Deep Learning Framework for SERS Bioquantification.
Article in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- AI/ML-Assisted SERS Biosensing for Biomolecular Detection: From Direct Spectral Response to Integrated Diagnostic Systems.Biosensors · 2026Review
- Next-Generation SERS Probes: Engineering Hotspots, Intelligent Molecular Targeting, and AI-Driven Spectral Analysis for Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Rapid Identification of Trace Pharmacodynamic Substances in Traditional Chinese Medicine via SERS and Deep Learning.Biosensors · 2026Article
- Application of surface-enhanced Raman spectroscopy in the diagnosis and treatment of breast cancer.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-enhanced Raman spectroscopy (SERS) is rapidly gaining attention as a fast and inexpensive method of biomarker quantification, which can be combined with deep learning to elucidate complex biomarker-disease relationships. Current standard practices in SERS analysis are behind the state-of-the-art machine learning approaches; however, the present challenges of SERS analysis could be effectively addressed with a robust computational framework. Furthermore, there is a need for improved model explainability for SERS analysis, which at present is insufficient in assessing the contexts in which confounding factors affect prediction outcomes. This study presents a framework for SERS bioquantification rooted in a three-step process, including spectral processing, quantification, and explainability. A serotonin quantification task in urine was assessed as a model task, with 682 SERS spectra measured in a micromolar range using cucurbit[8]uril chemical spacers. A denoising autoencoder was utilized for spectral enhancement, while convolutional neural networks (CNNs) and vision transformers were utilized for biomarker quantification. In addition, a context representative interpretable model explanation (CRIME) method was developed to suit the current needs of SERS mixture analysis explainability. Serotonin quantification was most efficient in denoised spectra analyzed using a CNN with a three-parameter logistic output layer (mean absolute error = 0.15 μM, mean percentage error = 4.67%). Subsequently, the CRIME method revealed the CNN model to present six unique prediction contexts, of which three were associated with serotonin. The proposed framework could unlock a novel, untargeted hypothesis-generating method of biomarker discovery, considering the rapid and inexpensive nature of SERS measurements and the potential to identify biomarkers from CRIME contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.